Physician
Legacy Clinics LLC
Legacy Clinics LLC was paid $48.79M by Medicaid between Jan 2018 and Dec 2024, across 153 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoLEGACY CLINICS LLC
PORTLAND, OR 97210
PORTLAND, OR 97210
33aNPI1902827272assigned 07/22/2006
33bProvider typeVascular Surgery Physician
28Total paid$48.79M
24GClaims809,900
24DCodes billed153
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Vascular Surgery Physician providers in Oregon
Rank by total paid#1 of 10
Median peer was paid$13K
This provider vs. median3,763×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,608 | $5.42M | |
| 2019 | 90,489 | $5.82M | |
| 2020 | 96,702 | $5.68M | |
| 2021 | 196,361 | $9.10M | |
| 2022 | 129,148 | $7.94M | |
| 2023 | 117,686 | $7.97M | |
| 2024incomplete | 97,906 | $6.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 165,866 | 157,282 | $10.86M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 101,181 | 95,129 | $8.36M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 59,285 | 57,011 | $4.91M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 8.6% | 72,919 | 29,349 | $4.19M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 7.7% | 28,418 | 12,864 | $3.76M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.9% | 82,285 | 77,912 | $3.38M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.2% | 11,999 | 11,587 | $1.55M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 35,325 | 33,022 | $1.52M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.0% | 35,305 | 15,866 | $1.46M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.9% | 14,823 | 13,624 | $1.44M |
| 0002A | 1.6% | 27,539 | 24,849 | $774K | |
| 0001A | 1.4% | 27,431 | 24,786 | $699K |
141 more codes
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 4,960 | $557K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.1% | 10,514 | $553K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.0% | 6,561 | $492K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15,737 | $429K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,668 | $421K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 4,564 | $333K |
| 99223 | Prolong inpt eval add15 m | <1% | 2,575 | $305K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,484 | $213K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,747 | $209K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,863 | $147K |
| 76801 | <1% | 1,482 | $139K | |
| 99205 | Prolong outpt/office vis | <1% | 892 | $125K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 5,370 | $115K |
| 19303 | <1% | 136 | $105K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,068 | $101K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 184 | $99K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 467 | $91K |
| 76813 | <1% | 873 | $86K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 805 | $80K |
| 20610 | <1% | 2,137 | $73K | |
| 95811 | <1% | 796 | $71K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 683 | $58K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,228 | $55K |
| 81025 | <1% | 8,713 | $54K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 317 | $50K |
| 99221 | <1% | 755 | $43K | |
| 73630 | <1% | 2,075 | $42K | |
| 81003 | <1% | 24,070 | $40K | |
| 73564 | <1% | 1,183 | $33K | |
| 99201 | <1% | 944 | $33K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 233 | $30K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 225 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,450 | $29K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 327 | $28K |
| 0012A | <1% | 1,875 | $26K | |
| 73030 | <1% | 1,370 | $24K | |
| 95806 | <1% | 605 | $24K | |
| 93000 | <1% | 2,705 | $24K | |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | <1% | 511 | $24K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,778 | $23K |
| 97597 | <1% | 1,507 | $22K | |
| 0031A | <1% | 544 | $18K | |
| 76825 | <1% | 122 | $18K | |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | <1% | 271 | $17K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 621 | $17K |
| 19318 | <1% | 19 | $15K | |
| 59025 | Fetal non-stress test | <1% | 330 | $13K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,504 | $13K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 931 | $13K |
| 99285 | Emergency room visit (most serious) | <1% | 95 | $12K |
| 87634 | <1% | 181 | $11K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 253 | $11K |
| 25600 | <1% | 40 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 646 | $11K |
| 0240U | <1% | 126 | $11K | |
| 73502 | <1% | 438 | $10K | |
| 19350 | <1% | 22 | $10K | |
| 90686 | <1% | 594 | $9K | |
| 73110 | <1% | 407 | $9K | |
| 0071A | <1% | 214 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 120 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 656 | $8K |
| 0004A | <1% | 233 | $8K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 232 | $8K |
| 20611 | <1% | 144 | $8K | |
| 93294 | <1% | 735 | $8K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 221 | $7K |
| 73100 | <1% | 254 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 579 | $7K |
| 0072A | <1% | 165 | $7K | |
| 93016 | <1% | 516 | $6K | |
| 0011A | <1% | 1,036 | $6K | |
| 99284 | Emergency room visit (serious) | <1% | 70 | $6K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 422 | $5K |
| 99305 | <1% | 351 | $5K | |
| 73560 | <1% | 197 | $5K | |
| 93018 | <1% | 582 | $5K | |
| 73562 | <1% | 248 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,226 | $4K |
| 64615 | <1% | 41 | $4K | |
| 76827 | <1% | 120 | $4K | |
| 93296 | <1% | 418 | $4K | |
| 99404 | <1% | 34 | $4K | |
| 76820 | <1% | 91 | $4K | |
| 93325 | <1% | 230 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 72 | $4K |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 67 | $4K |
| 93922 | <1% | 187 | $4K | |
| 99283 | Emergency room visit (moderate) | <1% | 85 | $4K |
| 46600 | <1% | 52 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 15 | $3K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 318 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 54 | $3K |
| 0064A | <1% | 101 | $3K | |
| 77427 | <1% | 20 | $3K | |
| 93298 | <1% | 154 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 68 | $3K |
| 73070 | <1% | 98 | $3K | |
| 99442 | <1% | 57 | $2K | |
| 95251 | <1% | 81 | $2K | |
| 77014 | <1% | 64 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 180 | $2K |
| 90674 | <1% | 113 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 120 | $2K |
| 73610 | <1% | 113 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $2K |
| 93454 | <1% | 13 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 12 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $2K |
| 72081 | <1% | 57 | $2K | |
| 99292 | <1% | 14 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 51 | $1K |
| 90673 | <1% | 30 | $1K | |
| 73130 | <1% | 77 | $1K | |
| 73140 | <1% | 52 | $988.78 | |
| 99183 | <1% | 25 | $980.71 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 61 | $841.51 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 152 | $792.08 |
| 73090 | <1% | 30 | $766.24 | |
| 96127 | <1% | 207 | $756.71 | |
| 90756 | <1% | 42 | $728.27 | |
| 91200 | <1% | 29 | $624.89 | |
| 99443 | <1% | 22 | $581.05 | |
| 97161 | <1% | 12 | $581.04 | |
| 93295 | <1% | 33 | $567.94 | |
| 0054A | <1% | 15 | $560.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 13 | $553.36 |
| 99459 | <1% | 29 | $508.56 | |
| 99441 | <1% | 15 | $452.95 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 27 | $304.44 |
| 99406 | <1% | 16 | $272.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 40 | $222.85 |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $176.42 |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | <1% | 62 | $153.50 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 132 | $99.49 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 13 | $48.16 |
| 90662 | <1% | 33 | $27.07 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 93 | $11.30 |
| G0008 | Administration of influenza virus vaccine | <1% | 20 | $2.84 |
| 91301 | 0% | 13 | $0.00 | |
| 91300 | 0% | 309 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJENSEN, SARAH (VP FINANCE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.